Help Baby Kriti Halder Fight Wilms Tumor (Pediatric Kidney Cancer)
Help Required ₹2,00,000
Standing With a Family in Their Hardest Battle
Medical Condition & Diagnosis
Baby Kriti Halder, aged just 1 year and 7 months, has been diagnosed with Wilms Tumor, a malignant tumor of the kidney that primarily affects infants and young children. According to medical records from Tata Medical Center, Kolkata, the tumor originated in her left kidney and required immediate medical intervention. Kriti was admitted under the Department of Paediatric Oncology and placed under the care of Dr. Arpita Bhattacharyya. Diagnostic imaging revealed a large renal mass involving the kidney, with complications that demanded urgent surgical and oncological management. She underwent a left nephrectomy (removal of the affected kidney) and has since begun chemotherapy as part of a curative treatment plan. Wilms Tumor, if treated in time, has a good survival rate, but delays or interruptions in treatment can be life-threatening.
Treatment Plan & Estimated Cost
As per the official cost estimate issued by Tata Medical Center, Kriti requires chemotherapy for a duration of approximately one year following surgery. The treatment intent is curative, but it involves multiple chemotherapy cycles, hospital visits, medications, diagnostic tests, and close monitoring to prevent complications such as infections or relapse. The estimated cost for chemotherapy alone is ₹2,00,000, and this amount may increase if complications arise, as clearly stated in the hospital disclaimer. Kriti has already received initial chemotherapy and tolerated it well, but continuity of treatment is absolutely critical. Any financial interruption may compromise her recovery and long-term survival. The hospital has appealed for financial assistance so that treatment can proceed without delay.
Family Background & Financial Hardship
Kriti belongs to an economically backward family residing in Lichutala village, Saguna, Nadia district, West Bengal. Her father, Mr. Kallol Halder, earns a monthly income of only ₹6,000, as certified by the Block Development Officer, Kalyani. The family has no health insurance coverage, no savings, and no alternative source of income. Meeting daily household expenses itself is a struggle, making it impossible for them to afford expensive cancer treatment. Despite their best efforts, the parents have exhausted all available resources to save their child. They have formally appealed for financial support, stating clearly that without external help, they cannot continue Kriti’s treatment. Supporting this case means directly helping a child complete her cancer treatment and giving her a fair chance at a healthy future.
Update 16 December 2025 - Help Baby Kriti Halder Fight Wilms Tumor (Pediatric Kidney Cancer)
Baby Kriti Halder is being treated as per standard pediatric oncology (SIOP) protocol for kidney tumor. She has received pre-operative chemotherapy, followed by surgery, and is now continuing post-operative chemotherapy for nearly 27 weeks.
Her treatment includes Vincristine and Actinomycin-D, along with regular scans, blood tests, and monitoring to ensure safe recovery and prevent relapse.
Total Estimated Cost of Treatment: ₹2,00,000This is a long and intensive treatment. Continued donor support is urgently needed to help Baby Kriti complete her care.
Update 22 December 2025
As of 15th December 2025, Baby Kriti Halder’s condition is stable, and her treating doctors have confirmed that her blood counts are within a safe range. She has successfully completed Week 8 of chemotherapy as part of her treatment for Wilms Tumor (pediatric kidney cancer). This is an important step forward in her ongoing cancer care. Her next medical review, along with blood investigations (CBC & renal panel), is scheduled for 26th December 2025. Based on the results of these tests, further chemotherapy will continue as per the prescribed treatment protocol. While Kriti is showing encouraging progress, her treatment journey is still ongoing and requires continued medical monitoring, hospital visits, and support. We humbly request your continued prayers and assistance to help her complete her life-saving treatment without interruption.
Update 26 December 2025 -
Baby Kriti Halder (1 year 9 months) is continuing her treatment for Wilms Tumor (left kidney) at Tata Medical Center, Kolkata. She has successfully undergone a left nephrectomy, and her disease is currently classified as Stage II (Intermediate Risk). She is now on adjuvant chemotherapy under the AV2 protocol. As per her latest clinical examination, Kriti is stable and doing well, and her recent blood investigations confirm that her counts are safe. As part of the ongoing treatment plan, Vincristine and Actinomycin-D chemotherapy is scheduled on 29th December 2025. This will be followed by blood tests and further evaluation on 2nd January 2026. Doctors are closely monitoring her progress and have advised supportive medications to help her tolerate the treatment smoothly. Kriti’s treatment is progressing as planned, and continued care and support remain essential during this phase.
Update 29 December 2025 -
Baby Kriti’s Ryles tube insertion has been changed successfully, and she has completed her scheduled chemotherapy session as part of her ongoing treatment for Wilms Tumor. She tolerated the procedure and chemotherapy well and continues to remain under close medical supervision. Her next Oncology OPD visit is scheduled for 2nd January 2026, during which further evaluation and treatment planning will be done as advised by the doctors. Kriti’s treatment is progressing step by step, and continued monitoring and care remain essential during this phase.
Update 3 January 2026 -
Baby Kriti Halder’s Oncology OPD visit was successfully completed on 2nd January 2026. As part of her ongoing treatment plan, Vincristine chemotherapy is scheduled for 5th January 2026. The treating doctor has also advised USG and X-ray investigations; however, the dates for these tests are yet to be confirmed. Regular blood tests and follow-up visits are continuing to closely monitor her condition and response to treatment. Baby Kriti remains under consistent medical supervision, and her treatment is progressing as advised by the oncology team. Update 6 January 2026 -
Baby Kriti will need to continue post-operative chemotherapy for a total duration of approximately 27 weeks. From January 2026 onwards, chemotherapy will continue with Vincristine given weekly in the initial phase and then on selected weeks, along with Actinomycin-D on specific scheduled weeks. The treating doctor has not provided exact calendar dates for the chemotherapy or investigations, as all treatment schedules depend on the baby’s blood reports and clinical condition. The doctor has also advised USG and X-ray investigations, though the dates are yet to be confirmed. Blood tests will be done before each cycle, and treatment may be delayed if counts are low. If required, doctors may also plan local radiotherapy at a later stage.
Update 9 January 2026 - Baby Kriti underwent a routine dressing procedure today. The procedure was completed successfully, and her condition remains stable. She continues to be under close medical supervision.
Her next OPD follow-up visit is scheduled for 12th January 2026. At present, the doctors have not shared further treatment details or the next chemotherapy schedule. The medical team is monitoring her progress closely and will decide the next course of treatment accordingly.
Update 10 January 2026Baby Kriti Halder attended her scheduled OPD visit on 09 January 2026. During this visit, required procedures including Ryles tube insertion and central line (CVAD) dressing and flushing were performed successfully. Her CVAD and Ryles tube are being monitored regularly and are currently in healthy condition, with no signs of infection or complications. Baby Kriti remains stable and continues to receive close medical supervision. Her next OPD visit is scheduled for 12 January 2026, during which the doctors will review her condition and plan the next phase of treatment accordingly.
Why Your Support Matters
Baby Kriti is battling a curable but deadly childhood cancer. Timely chemotherapy is essential for her survival.
Transparency You Can Trust
This case is verified with hospital documentation. Treatment cost is issued by Tata Medical Center.
Be the Reason to Save a Life
Kriti’s future depends on continued treatment. Her parents cannot afford this battle alone.